The MARVEL project
“Evolving reversible immunocapture by membrane sensing peptides: towards scalable extracellular vesicles isolation” – brings innovation to healthcare and especially to its diagnostic and therapeutic tools.
Find out more

news from EVengers

Meeting report of the 2nd Lugano ExoDay
29.7.2022
The meeting report of our 2nd Lugano ExoDay: extracellular vesicles as next-generation clinical biomarkers and ...
How we attended the ISEV 2022 Annual Meeting in Lyon, France
25.5.2022
On 25-29 May, two of our MARVEL partners, CNR SCITEC ‘Giulio Natta’ and HansaBioMed Life ...
Watch how was our MARVEL project symposium in Lugano
3.5.2022
https://www.youtube.com/watch?v=_tkoyZOBOGY&ab_channel=AMIRESvideo On 13 April 2022, we had an Extracellular Vesicles (EVs) dedicated symposium in Lugano, Switzerland ...
MARVEL project symposium
13.4.2022
REGISTRATION IS FINISHED 📣 GOOD NEWS! The capacity of the registered attendees for the MARVEL Extracellular Vesicles ...
MARVEL M18 MEETING | LUGANO, SWITZERLAND
12.4.2022
We are happy to meet in person again and this time in Lugano, Switzerland. Our ...
Happy International Women’s Day from MARVEL Consortium
8.3.2022
Our MARVEL project Consortium searches gender equality and as an example it is perfectly gender-balanced. ...
Merry Christmas and Happy New Year 2022!
21.12.2021
Marvel Project and all #EVengers wish you a peaceful Christmas break and a marvelous start ...
Extracellular Vesicles (EVs) as innovative drugs: large scale GMP manufacturing
3.12.2021
Cardiac progenitor cells secrete exosomes, nanosized extracellular vesicles (EV) with anti-apoptotic and pro-angiogenic biological activities. ...
Save the date – MARVEL workshop
3.12.2021
SAVE THE DATE 🗓️ – come to share📣 or to know more📔! We are bringing ...
MARVEL Project – ONE YEAR ANNIVERSARY
15.11.2021
One year after the start of the project and we finally had our first in-person ...